Algorithms for the assessment and management of insomnia in primary care

Patient Preference and Adherence

Volumn 3, Issue , 2009, Pages 9-20

  Hilty, Donald ^a   Young, Julie S ^a   Bourgeois, James A ^a   Klein, Sally ^b   Hardin, Kimberly A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; Depression; Disorder; Insomnia; Primary care; Sleep

Indexed keywords

EID: 84855990176     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S2670     Document Type: Article

References (43)

1. International Classification of Sleep Disorders. American Academy of Sleep Medicine, One Westbrook Corporate Center, Westchester, IL, 60154, 2001.
2. National Institute of Health. NIH state-of-the-science conference statement on manifestations and management of chronic insomnia in adults. NIH Consens Stat Sci Statements. 2005;22:1-30.
3. Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract. 2002;51:229-235.
4. National Sleep Foundation. 2005. Cited Oct 6, 2008. Available from: http://www.sleepfoundation.org.
5. Bliwise DL. Review: Sleep in normal aging and dementia. Sleep. 1993;16:40-81.
6. Ford DE, Kamerow DB. Epidmiologic study of sleep disturbances and psychiatric disorders: An opportunity for prevention? JAMA. 1989;262:1479-1484.
7. Zorick FJ. Evaluation and management of insomnia: An overview. In: Kryger MH, Roth T, Dement WC (editors). Principles and Practice of Sleep Medicine. 3rd Ed. Philadephia: W.B. Saunders Company; 2000. p. 615-616.
8. Richardson G. Update on the science, diagnosis and management of insomnia. London: Royal Society of Medicine Press Ltd, International Congress and Symposium Series; 2006. p. 262.
9. BaHamman A. Sleep in acute care units. Sleep Breath. 2006;10:6-15.
10. Ballard RD. Sleep and medical disorders. Prim Care Clin Office Pract. 2005;35:511-533.
11. Berry RB, Harding SM. Sleep and medical disorders. Med Clin N Am. 2004;88:679-703.
12. Mohsenin V. Sleep in chronic obstructive pulmonary disease. Sleep Med Clin. 2007;2:1-8.
13. Hanly P. Sleep disorders and end-stage renal disease. Sleep Med Clin. 2007;2:59-66.
14. Gislason T, Almqvist M. Somatic diseases and sleep complaints: An epidemiologic study of 3,201 Swedish men. Acta Med Scand. 1987;221:475-481.
15. Lamond N, Tiggermann M, Dawson D. Factors predicting sleep disruption in type II diabetes. Sleep. 2000;23:415-416.
16. Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care. 2006;29:657-661.
17. Hoyt BD. Sleep in patients with neurologic and psychiatric disorders. Prim Care Clin Off Pract. 2005;32:535-548.
18. Fichtenberg NL, Zafonte RD, Putnam S, Mann NR, Millard AE. Insomnia in a post-acute brain injury sample. Brain Inj. 2002;16:197-206.
19. Barczi SR, Juergens TM. 2006. Comorbidities: Psychiatric, medical, medications, and substances. Sleep Med Clin. 2006;1:231-245.
20. Lineberger MD, Means JK, Edinger JD. Sleep disturbance and fibromyalgia. Sleep Med Clin. 2007;2:31-39.
21. Raymond I, Ancoli-Israel S, Choiniere M. Sleep disturbances, pain and analgesia in adults hospitalized for burn injuries. Sleep Med. 2004;5:551-559.
22. United States Health and Human Services. Frequently asked questions. 2008. Cited Oct 6, 2008. Available from: http://www.4woman.gov/ FAQ/insomnia.htm.
23. Kalleinen N, Polo-Kantola P, Himanen SL, et al. Sleep and the menopause-do postmenopausal women experience worse sleep than premenopausal women? Menopause Int. 2008;14:97-104.
24. Rocha FL, Hara C, Rodriguez CV, et al. Is insomnia a marker for psychiatric disorders in general hospitals? Sleep Med. 2005;6:549-553.
25. Weissman MM, Greenwald S, Nino-Murcia G, et al. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psych. 1997;19:245-250.
26. Peterson MJ, Benca RM. Sleep in mood disorders. Psychiatr Clin N Am. 2006;29:1009-1032.
27. Bassiri AG, Guilleminault C. Clinical features and evaluation of obstructive sleep apnea-hypopnea syndrome. In: Kryger MH, Roth T, Dement WC (editors). Principles and Practice of Sleep Medicine. 3rd Ed. Philadephia: W.B. Saunders Company; 2000. p. 869-872.
28. Wattanakit E, Boland L, Punjabi NM, et al. Relation of sleep-disordered breathing to carotid plaque and intima-media thickness. Atherosclerosis. In press.
29. Edinger JD, Wohlgemuth WK, Radtke RA, et al. Dose-response effects of cognitive-behavioral insomnia therapy: a randomized clinical trial. Sleep. 2007;30:203-212.
30. Zavesicka L, Brunovsky M, Matousek M, et al. Discontinuation of hypnotics during cognitive behavioural therapy for insomnia. BMC Psychiatry. 2008;8:80.
31. Espie CA, MacMahon KM, Kelly HL, et al. Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep. 2007;30:574-584.
32. Green BT, Broughton WA, O'Connor JB. Marked improvement in nocturnal gastroesophageal reflux in a large cohort of patients with obstructive sleep apnea. Arch Intern Med. 2003;163:41-45.
33. Neubauer DB. State-of-the-art sleep management. Awakening insomnia management. Proceedings from a satellite symposium at SLEEP 2006: 20th Anniversary Meeting of the Associated Professional Sleep Societies, Salt Lake City, UT, June 20. 2006, p. 6-12.
34. Dundar Y, Boland A, Strobl J, et al. Newer hypnotic drugs for the short-term management of insomnia: A systematic review and economic evaluation. Health Tech Ass. 2004;19:305-322.
35. Pagel JF. Medications and their effect on sleep. Prim Care Clin Off Pract. 2005;32:401-509.
36. Erman MK, Zammit G, Rubens R, et al. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia. J Clin Sleep Med. 2008;4:229-234.
37. Pollack M, Kinrys G, Krystal A, et al. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry. 2008;65:551-562.
38. Walsh JK, Krystal AD, Amato DA, et al. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep. 2007;30:959-968.
39. Krystal AD, Erman M, Zammit GK, et al. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep. 2008;31:79-90.
40. Erman M, Seiden D, Zammit G, et al. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep Med. 2006;7:17-24.
41. Turek FW, Gillette MU. Melatonin, sleep, and circadian rhythms: Rationale for development of specific melatonin agonists. Sleep Med. 2004;5:523-532.
42. Infante M, Benca R. Treatment of insomnia. Primary Psychiatry. 2005;12:47-56.
43. Hilty DM, Leamon ML, Lim RF, et al. Diagnosis and treatment of bipolar disorder in the primary care setting. Primary Psychiatry. 2006;13:77-85.